Showing results (1-10 of 10) with videos related to
Sort By:
Pageof 1
Cardiology|June 13, 2015
Late Silent Stent AbscessDmitry Zateyshchikov, Elvira Fattakhova, Vladimir Demchinsky, et al.International Journal of Molecular Sciences|April 12, 2022
Circulating miR-499a-5p Is a Potential Biomarker of <i>MYH7</i>-Associated Hypertrophic CardiomyopathyNatalia Baulina, Maria Pisklova, Ivan Kiselev, et al.Journal of Structural Biology|March 16, 2026
Molecular dynamics simulations refine the pathogenicity of ACVRL1 kinase domain variants by quantifying impacts on ATP binding in pulmonary arterial hypertensionIrina Borovikova, Igor Uporov, Galina Okhrimenko, et al.Pharmacogenomics|September 12, 2022
A survey of physician opinions in Russia in the field of pharmacogenetics of cardiovascular diseaseDmitry Sychev, Ludmila Fedina, Maria Poptsova, et al.International Journal of Molecular Sciences|December 11, 2022
Novel Genes Involved in Hypertrophic Cardiomyopathy: Data of Transcriptome and Methylome ProfilingIvan Kiselev, Maxim Kozin, Natalia Baulina, et al.Respiratory Research|April 14, 2025
The prevalence of pathogenic variants in the BMPR2 gene in patients with the idiopathic pulmonary arterial hypertension in the Russian population: sequencing data and meta-analysisGalina Okhrimenko, Irina Borovikova, Elena Dankovtseva, et al.The Pharmacogenomics Journal|February 7, 2020
CYP2C9 and VKORC1 genotyping for the quality of long-standing warfarin treatment in Russian patientsElizaveta Panchenko, Ekaterina Kropacheva, Anatoly Dobrovolsky, et al.The New England Journal of Medicine|September 3, 2019
Ticagrelor in Patients with Stable Coronary Disease and DiabetesP Gabriel Steg, Deepak L Bhatt, Tabassome Simon, et al.Drugs - Real World Outcomes|February 21, 2024
Diagnosis and Treatment Patterns of Chronic Thromboembolic Pulmonary Hypertension in Russia, Kazakhstan, Turkey, Lebanon, and Saudi Arabia: A Registry StudyHürrem Gül Öngen, Bahri Akdeniz, Mehmet Akif Düzenli, et al.European Heart Journal|July 15, 2021
Alpha-protein kinase 3 (ALPK3) truncating variants are a cause of autosomal dominant hypertrophic cardiomyopathyLuis R Lopes, Soledad Garcia-Hernández, Massimiliano Lorenzini, et al.Pageof 1